KOD News and Press, Kodiak Sciences Inc From 08/13/25

Kodiak Sciences Inc (KOD) is expected to report $-1.01 for Q2 2025

Kodiak Sciences to Host Investor R&D Day on July 16, 2025 Kodiak Sciences to Host Investor R&D Day on July 16, 2025 PR Newswire PALO ALTO, Calif. , July 10, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotec...

Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society PR Newswire PALO ALTO, Calif. , June 25, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching,...

2025-06-17 21:14:09 ET This article is part of a series that provides an ongoing analysis of the changes made to Baker Brothers' 13F stock portfolio on a quarterly basis. It is based on Baker Brothers' regulatory 13F Form filed on 05/15/2025. The 13F portfolio value decreased from $...

2025-06-12 11:03:51 ET Investment Overview Back in January this year, I covered EyePoint Pharmaceuticals, Inc. ( EYPT ) in a note for Seeking Alpha , calling its stock a "risky buy" ahead of a key readout for its lead and only clinical stage drug candidate Du...

Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference PR Newswire PALO ALTO, Calif. , May 29, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transfo...

2025-05-14 17:28:44 ET More on Kodiak Sciences Kodiak Sciences: Anti-VEGF Could Win Nicely On Retinal Disorders Seeking Alpha’s Quant Rating on Kodiak Sciences Historical earnings data for Kodiak Sciences Financial information for Kodiak Sciences ...

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2025 Financial Results PR Newswire PALO ALTO, Calif. , May 14, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the ...

Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases PR Newswire PALO ALTO, Calif. , May 1, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company...

2025-04-21 11:57:19 ET Kodiak Sciences Inc. (NASDAQ: KOD) is one of today’s top gainers. The company’s shares have moved 12.5% on the day to $3.19. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics t...